Skip to content
healthcare.dev
Get a free key

Sulfasalazine

NDC 11534-201, Sulfasalazine, tablet, delayed release, from Sunrise Pharmaceutical, Inc..

Product NDC
11534-201
Status
Listed
Labeler
Sunrise Pharmaceutical, Inc.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075339
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11534-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SULFASALAZINE500 mg/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
11534-201-0111534020101100 TABLET, DELAYED RELEASE in 1 BOTTLE (11534-201-01)
11534-201-0711534020107300 TABLET, DELAYED RELEASE in 1 BOTTLE (11534-201-07)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d596ac59-b643-4181-80ba-f2db1cc3459c

Use it

Look up 11534-201 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11534-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11534-201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.